XFCI yields 2000000.00% · JNJ yields 2.13%● Live data
📍 XFCI pulled ahead of the other in Year 1
Combined, XFCI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XFCI + JNJ for your $10,000?
Xtreme Fighting Championships, Inc. operates as a sports entertainment and media company. The company produces a range of live fighting events that are broadcast through traditional networks, pay-per-view, and online. It engages in the mixed martial arts (MMA) league businesses. The company produces and promotes live XFC fighting events featuring a range of MMA fighters in all major weight classes for men and women; provides talent development services; and develops advertising and sponsorship programs that would extend live events to broadcast and social media content. It is also involved in broadcasting and promoting events on various traditional and internet media; and developing merchandise to promote the company's XFC brand among consumers and MMA sports enthusiasts. The company was formerly known as Duke Mountain Resources, Inc. and changed its name to Xtreme Fighting Championships, Inc. in July 2020. Xtreme Fighting Championships, Inc. was incorporated in 2006 and is headquartered in Miramar Beach, Florida.
Full XFCI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.